As i mentioned once before I own another company that has partnered Japan only for stroke, as I suggest IPIX should do with ABSSSI, that other co. had a similar mkt cap about a year ago, it now has a MC approaching 3 times IPIX's, primarily due to that partnership. Partnering is the name of the game for public pre-revenue bio in this market climate, so why not partner in a foreign country with a regional player preserving the largest markets. Not so much for revenue but rather to off load the expense of advancing the pipeline.